BE843437A - 11 beta fluoro-androstenes et leur procede de preparation - Google Patents

11 beta fluoro-androstenes et leur procede de preparation

Info

Publication number
BE843437A
BE843437A BE168339A BE168339A BE843437A BE 843437 A BE843437 A BE 843437A BE 168339 A BE168339 A BE 168339A BE 168339 A BE168339 A BE 168339A BE 843437 A BE843437 A BE 843437A
Authority
BE
Belgium
Prior art keywords
androstenes
preparation process
fluoro
beta
beta fluoro
Prior art date
Application number
BE168339A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE843437A publication Critical patent/BE843437A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE168339A 1975-06-25 1976-06-25 11 beta fluoro-androstenes et leur procede de preparation BE843437A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528879 DE2528879A1 (de) 1975-06-25 1975-06-25 11 beta-fluor-androstene

Publications (1)

Publication Number Publication Date
BE843437A true BE843437A (fr) 1976-12-27

Family

ID=5950147

Family Applications (1)

Application Number Title Priority Date Filing Date
BE168339A BE843437A (fr) 1975-06-25 1976-06-25 11 beta fluoro-androstenes et leur procede de preparation

Country Status (8)

Country Link
JP (1) JPS523050A (de)
BE (1) BE843437A (de)
DD (1) DD124988A5 (de)
DE (1) DE2528879A1 (de)
DK (1) DK252276A (de)
FR (1) FR2316958A1 (de)
LU (1) LU75229A1 (de)
NL (1) NL7606822A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439487A (en) * 1982-12-17 1984-03-27 E. I. Du Pont De Nemours & Company Polyester/nylon bicomponent flament

Also Published As

Publication number Publication date
NL7606822A (nl) 1976-12-28
JPS523050A (en) 1977-01-11
FR2316958A1 (fr) 1977-02-04
DD124988A5 (de) 1977-03-23
LU75229A1 (de) 1977-02-18
DK252276A (da) 1976-12-26
DE2528879A1 (de) 1977-01-13

Similar Documents

Publication Publication Date Title
FR2449699B1 (fr) Polyetherpolyamides et leur procede de preparation
FR2335596A1 (fr) Compositions de blanchiment et leur procede de preparation
BE849794A (fr) Derives de carbostyrile et leur procede de preparation
BE863872A (fr) Steroides-11 beta-substitues et procede de leur preparation
FR2318645A1 (fr) 3-oximes d'esters de d-17a-ethynyl-19-nortestosterone et leur procede de preparation
FR2299032A1 (fr) Derives de tetrahydroisoquinoleine et leur procede de preparation
FR2301521A1 (fr) Nouvelles n-acyl-n-norsalutaridines et leur procede de preparation
FR2280386A1 (fr) 7-methoxy-6-thia-tetracyclines et leur procede de preparation
BE856220A (fr) Polyether-polyureides et procede de leur preparation
BE884652R (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
BE830814A (fr) N-alkyl-iminoalanes oligomeres et leur procede de preparation
FR2347370A1 (fr) 7-amino-3-tetrazolyl substitue-thiomethyl-cephalosporines et leur procede de preparation
FR2299865A1 (fr) Arylmethyl-1 imidazolidones-2 et leur procede de preparation
FR2424281B1 (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
FR2333792A1 (fr) 4-hydroxymethyl-2-pyrrolidinones et leur procede de preparation
BE826139A (fr) 11beta-fluoro-androstenes et leur procede de preparation
BE862066A (fr) Agents anti-rhinovirus et procede de leur preparation
FR2329267A2 (fr) Styrylamidines et leur procede de preparation
FR2352830A1 (fr) Derives de la neamine et leur procede de preparation
BE824179A (fr) Bis-dihalogeno-s-triazinyl-urees et leur procede de preparation
FR2313073A1 (fr) Cholestenes-5 aminomethyles en 6 et oxygenes en 3 et leur procede de preparation
BE843437A (fr) 11 beta fluoro-androstenes et leur procede de preparation
BE838689A (fr) Acides indanylpropioniques substitues et leur procede de preparation
FR2309230A1 (fr) Derives de triazolocycloalkylthiadiazine et leur procede de preparation
FR2311537A1 (fr) Derives de 3-nitropyrazole et leur procede de preparation